The Global Endoscope Reprocessing Market size is expected to reach $2.8 billion by 2031, rising at a market growth of 9.0% CAGR during the forecast period.
There has been a steady increase in the number of endoscopic procedures performed in North America. This is due to factors such as an ageing population, which requires more diagnostic and therapeutic procedures, and advancements in endoscopic technology that make these procedures more accessible and effective. Regulatory bodies in North America, such as the FDA in the United States and Health Canada, have implemented strict guidelines for endoscope reprocessing to prevent healthcare-associated infections (HAIs). Thus, the North region acquired 39% revenue share in the market 2023.
Infections acquired by patients during the course of medical or surgical treatment constitute healthcare-associated infections (HAIs), which present a critical hazard to safety. The prevalence of HAIs has highlighted the urgent need for stringent infection control measures within healthcare settings.
Additionally, the ASP AEROFLEX AER uses a peracetic acid-based disinfectant, which is highly effective at low temperatures, ensuring thorough disinfection without damaging delicate endoscope components. Hence, technological advancements are aiding in the expansion of the market.
However, the initial investment required to purchase automated endoscope reprocessors (AERs), high-quality disinfectants, and other necessary accessories can be substantial. For instance, a single AER can cost tens of thousands of dollars, not including the additional expenses for installation, training, and integration with existing systems.
There has been a steady increase in the number of endoscopic procedures performed in North America. This is due to factors such as an ageing population, which requires more diagnostic and therapeutic procedures, and advancements in endoscopic technology that make these procedures more accessible and effective. Regulatory bodies in North America, such as the FDA in the United States and Health Canada, have implemented strict guidelines for endoscope reprocessing to prevent healthcare-associated infections (HAIs). Thus, the North region acquired 39% revenue share in the market 2023.
Infections acquired by patients during the course of medical or surgical treatment constitute healthcare-associated infections (HAIs), which present a critical hazard to safety. The prevalence of HAIs has highlighted the urgent need for stringent infection control measures within healthcare settings.
Additionally, the ASP AEROFLEX AER uses a peracetic acid-based disinfectant, which is highly effective at low temperatures, ensuring thorough disinfection without damaging delicate endoscope components. Hence, technological advancements are aiding in the expansion of the market.
However, the initial investment required to purchase automated endoscope reprocessors (AERs), high-quality disinfectants, and other necessary accessories can be substantial. For instance, a single AER can cost tens of thousands of dollars, not including the additional expenses for installation, training, and integration with existing systems.
Driving and Restraining Factors
Drivers- Growing awareness about infection control
- Technological advancements in endoscope reprocessing
- Increasing incidence of endoscopic procedures
- High costs associated with advanced endoscope reprocessing equipment
- Complexity of reprocessing procedures
- Expansion of healthcare infrastructure
- Rising geriatric population worldwide
- Substantial lack of skilled professionals
- Limited awareness in developing regions
End User Outlook
By end-use, the market is divided into hospitals and outpatient facilities. The hospitals segment garnered 44% revenue share in the market in 2023. Hospitals perform a large number and variety of medical procedures that require the use of endoscopes.Products Outlook
Based on product, the market is characterised by high-level disinfectants & test strips, detergents & wipes, automated endoscope reprocessors (AERs), endoscope drying, storage, & transport systems, and others. The high-level disinfectants and test strips segment garnered 29% revenue share in the market in 2023.Automated endoscope reprocessors (AERs) type Outlook
On the basis of automated endoscope reprocessors (AERs) type, the market is bifurcated into single basin and double basin. The single basin segment garnered 60% revenue share in the market in 2023. The segment's growth can be attributed to its cost-effectiveness, ease of use, and space-saving design.Automated endoscope reprocessors (AERs) portability Outlook
By automated endoscope reprocessors (AERs) portability, the market is segmented into standalone AER and portable AER. The standalone AER segment garnered the 64% revenue share in the market in 2023. Its robust performance, reliability, and ability to handle high-volume reprocessing demands drive the growth.Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Europe segment acquired 29% revenue share in the market in 2023. In Europe, healthcare professionals and the general public are becoming more aware of the risks of improperly reprocessed endoscopes.List of Key Companies Profiled
- Belimed AG (Metall Zug AG)
- ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
- Ecolab, Inc.
- Getinge AB
- Steelco S.p.A. (Miele Group)
- ARC Healthcare Solutions Inc.
- Metrex Research, LLC (Envista Holdings Corporation)
- Shinva Medical Instrument Co., Ltd.
Market Report Segmentation
By End-use- Outpatient Facilities
- Hospitals
- High-level Disinfectants & Test Strips
- Detergents & Wipes
- Automated Endoscope Reprocessors (AERs)
- Type
- Single Basin
- Double Basin
- Portability
- Standalone AER
- Portable AER
- Endoscope Drying, Storage, & Transport Systems
- Others
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Global Endoscope Reprocessing Market by End-use
Chapter 5. Global Endoscope Reprocessing Market by Product
Chapter 6. Global Endoscope Reprocessing Market by Region
Chapter 7. Company Profiles
Companies Mentioned
- Belimed AG (Metall Zug AG)
- ASP Global Manufacturing GmbH (FORTIVE CORPORATION)
- Ecolab, Inc.
- Getinge AB
- Steelco S.p.A. (Miele Group)
- ARC Healthcare Solutions Inc.
- Metrex Research, LLC (Envista Holdings Corporation)
- Shinva Medical Instrument Co., Ltd.
Methodology
LOADING...